VISI: The Videolaryngoscopy in Small Infants

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Completed
CT.gov ID
NCT03396432
Collaborator
Anesthesia Patient Safety Foundation (Other)
566
5
2
30.9
113.2
3.7

Study Details

Study Description

Brief Summary

Complications related to infant (≤ 1 year) airway management are under-appreciated because of few rigorous and targeted studies. Investigators have recently shown that multiple tracheal intubation (TI) attempts are a key risk factor for intubation-related complications in small children. Tracheal Intubation using Video laryngoscopy (VL) has become popular in anesthesiology practice because of several advantages over conventional direct laryngoscopy (DL). Studies show that VL improves the view of the airway compared to DL, requires fewer intubation attempts, but may take more time to intubate the trachea. This study compares first attempt success of VL to DL in infants presenting for elective surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: Video Laryngoscopy for ET placement
  • Device: Direct Laryngoscopy for ET Placement
N/A

Detailed Description

Objectives:
  • Primary Objective To compare the tracheal intubation (TI) first attempt success rate using VL vs. DL in children ≤ 12 months old.

  • Secondary Objectives To compare the lowest oxygen saturation during tracheal intubation with VL vs. DL.

Study Design:

Prospective, randomized, multi-center parallel group trial

Setting/Participants:

This will be a multi-center study with a minimum of four participating centers. The target population will be children ≤ 12 months age scheduled for elective surgery requiring general anesthesia with endotracheal intubation.

Study Interventions and Measures:

The study intervention will be a 1:1 randomization to perform tracheal intubation with the Storz C-Mac Miller 1 (VL) or the conventional Miller laryngoscope (DL).

Main study outcome measures are as follows:
  • The first intubation attempt success rate with each device

  • The number of attempts for successful intubation with each device

  • Complications associated with intubation

Study Design

Study Type:
Interventional
Actual Enrollment :
566 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective, randomized, multi-center parallel group trialProspective, randomized, multi-center parallel group trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Statistician will be blinded at the time of data analysis.
Primary Purpose:
Other
Official Title:
The Videolaryngoscopy in Small Infants (VISI) Trial
Actual Study Start Date :
Jun 4, 2018
Actual Primary Completion Date :
Aug 19, 2019
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Video Laryngoscopy for endotracheal (ET) Placement

Device: Storz C-MAC Video Laryngoscope

Device: Video Laryngoscopy for ET placement
Tracheal intubation performed with the Storz C-Mac Video Laryngoscope

Device: Direct Laryngoscopy for ET Placement
Tracheal Intubation performed with the Miller Blade

Active Comparator: Direct Laryngoscopy for ET Placement

Device: Miller Laryngoscope

Device: Video Laryngoscopy for ET placement
Tracheal intubation performed with the Storz C-Mac Video Laryngoscope

Device: Direct Laryngoscopy for ET Placement
Tracheal Intubation performed with the Miller Blade

Outcome Measures

Primary Outcome Measures

  1. Number of Participants With Success in the First Attempt [at the time of intubation]

    comparing the tracheal intubation (TI) first attempt success rate using VL vs. DL

Secondary Outcome Measures

  1. Hypoxia [At the time of intubation]

    Comparing the lowest oxygen saturation during tracheal intubation with VL vs. DL

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 12 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  1. Males or females age 0 to <12 months.

  2. Scheduled for non-cardiac surgery or procedure lasting longer than 30 minutes under general anesthesia where oral endotracheal intubation will be performed by an anesthesiology clinician.

  3. Subject/Parental/guardian permission (informed consent).

Inclusion for clinician participants:
  1. Pediatric anesthesia attending, pediatric anesthesia fellows, and anesthesia resident

Exclusion Criteria

  1. History of difficult intubation

  2. History with abnormal airway

  3. Predictive of difficult intubation upon physical examination

  4. Parents/guardians who, in the opinion of the investigator, may be unable to understand or give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Boston Children's Hospital Boston Massachusetts United States 02115
2 The Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104
3 UT Southwestern Medical Center Dallas Texas United States 75390
4 Seattle Children's Hospital Seattle Washington United States 98105
5 Princess Margaret Hospital For Children Subiaco Perth Australia

Sponsors and Collaborators

  • Children's Hospital of Philadelphia
  • Anesthesia Patient Safety Foundation

Investigators

  • Principal Investigator: John Fiadjoe, MD, Children's Hospital of Philadelphia

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT03396432
Other Study ID Numbers:
  • 17-014302
First Posted:
Jan 11, 2018
Last Update Posted:
Mar 25, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Children's Hospital of Philadelphia

Study Results

Participant Flow

Recruitment Details The study was recruited per protocol without any protocol deviation or violation.
Pre-assignment Detail The block size was varying among 2, 4, 6 to avoid the predictability of device assignment. To further balance device assignment, we'll stratify the randomization by study site and clinician's role. Separate randomization schedule was generated for each stratum.
Arm/Group Title Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Arm/Group Description Device: Storz C-MAC Video Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade Device: Miller Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade
Period Title: Overall Study
STARTED 283 283
COMPLETED 274 277
NOT COMPLETED 9 6

Baseline Characteristics

Arm/Group Title Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement Total
Arm/Group Description Device: Storz C-MAC Video Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade Device: Miller Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade Total of all reporting groups
Overall Participants 274 277 551
Age, Customized (Count of Participants)
0-30 Days
17
6.2%
20
7.2%
37
6.7%
31-90 Days
55
20.1%
64
23.1%
119
21.6%
> 90 Days
202
73.7%
193
69.7%
395
71.7%
Sex: Female, Male (Count of Participants)
Female
79
28.8%
96
34.7%
175
31.8%
Male
195
71.2%
181
65.3%
376
68.2%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Weight (kg) (kg) [Median (Inter-Quartile Range) ]
Median (Inter-Quartile Range) [kg]
6.5
6.6
6.5
ASA (Count of Participants)
1 - Normal
58
21.2%
72
26%
130
23.6%
2 - Mild systemic disease
133
48.5%
136
49.1%
269
48.8%
>= 2 - Mod - Severe systemic disease
83
30.3%
69
24.9%
152
27.6%
Induction Technique -IV (Count of Participants)
Count of Participants [Participants]
28
10.2%
39
14.1%
67
12.2%
Muscle Relaxant (Count of Participants)
None
15
5.5%
14
5.1%
29
5.3%
Succinylcholine
9
3.3%
11
4%
20
3.6%
Other
250
91.2%
252
91%
502
91.1%
Device experience as number of infant intubations (Count of Participants)
0
38
13.9%
10
3.6%
48
8.7%
1-10
79
28.8%
59
21.3%
138
25%
11-20
36
13.1%
36
13%
72
13.1%
21-50
49
17.9%
37
13.4%
86
15.6%
>50
62
22.6%
128
46.2%
190
34.5%
Unknown
10
3.6%
7
2.5%
17
3.1%
Provider Role (Count of Participants)
Anes Attending
69
25.2%
69
24.9%
138
25%
Anes Fellow
99
36.1%
102
36.8%
201
36.5%
Anes Resident
106
38.7%
106
38.3%
212
38.5%

Outcome Measures

1. Primary Outcome
Title Number of Participants With Success in the First Attempt
Description comparing the tracheal intubation (TI) first attempt success rate using VL vs. DL
Time Frame at the time of intubation

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Arm/Group Description Device: Storz C-MAC Video Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade Device: Miller Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade
Measure Participants 274 277
Count of Participants [Participants]
253
92.3%
243
87.7%
2. Secondary Outcome
Title Hypoxia
Description Comparing the lowest oxygen saturation during tracheal intubation with VL vs. DL
Time Frame At the time of intubation

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Arm/Group Description Device: Storz C-MAC Video Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Device: Miller Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade
Measure Participants 274 277
Count of Participants [Participants]
9
3.3%
15
5.4%

Adverse Events

Time Frame Upon discharge from PACU or up to 24 hr after intubation
Adverse Event Reporting Description
Arm/Group Title Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Arm/Group Description Device: Storz C-MAC Video Laryngoscope Video Laryngoscopy for ET placement: Tracheal intubation performed with the Storz C-Mac Video Laryngoscope Device: Miller Laryngoscope Direct Laryngoscopy for ET Placement: Tracheal Intubation performed with the Miller Blade
All Cause Mortality
Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/274 (0%) 0/277 (0%)
Serious Adverse Events
Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/274 (0%) 0/277 (0%)
Other (Not Including Serious) Adverse Events
Video Laryngoscopy for Endotracheal (ET) Placement Direct Laryngoscopy for ET Placement
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 3/274 (1.1%) 2/277 (0.7%)
Cardiac disorders
Intermittent tachypnea 1/274 (0.4%) 1 0/277 (0%) 0
Respiratory, thoracic and mediastinal disorders
Stridor 0/274 (0%) 0 1/277 (0.4%) 1
Brief Desaturation 2/274 (0.7%) 3 1/277 (0.4%) 1

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. John Fiadjoe, PI
Organization Children Hospital of Philadelphia
Phone 267-426-2961
Email fiadjoej@email.chop.edu
Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT03396432
Other Study ID Numbers:
  • 17-014302
First Posted:
Jan 11, 2018
Last Update Posted:
Mar 25, 2021
Last Verified:
Mar 1, 2021